Hôpital Bretonneau Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2015
NCT03340896
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Hôpital Bretonneau, Service CORad Pôle Henry S Kaplan

Active Ingredients

Drugs in Phase 3 Trials (3)

cisplatin (platinol) (1 trial)

docetaxel (taxotere) (1 trial)

fluorouracil (efudex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Squamous Cell Carcinoma of Head and Neck (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3